That temporary waiver has been extended multiple times and is now active through December 31, 2026 (www.hhs.gov)
Antioxidant formulas
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Bisanz J.E., Enos M.K., PrayGod G., Seney S., Macklaim J.M., Chilton S., Willner D., Knight R., Fusch C., Fusch G., et al
These GI effects are the best-supported use in animal data
Medical Evaluation Rule Out Key Risks Your physician must first rule out serious pre-existing conditions where GLP-1 analogues are contraindicated: History of pancreatitis Medullary thyroid carcinoma (MTC) or family history of MEN-2 (contraindicated) Severe gastrointestinal disease (gastroparesis, severe reflux) Significant renal impairment (dose adjustment/avoid in severe CKD) Baseline labs: fasting glucose, HbA1c, renal & liver function